Feb 09, 2026
Epilepsy is a chronic neurological disorder that affects millions of people across the globe and is characterized by recurrent, unprovoked seizures. Despite major advances in neuroscience and pharmacology, epilepsy remains surrounded by social stigma, misconceptions, and unanswered questions. In the 7MM, the total ...
Read More...
Aug 09, 2025
Epilepsy is a chronic neurological condition characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. Affecting over 50 million people globally, it remains one of the most prevalent neurological disorders. Understanding the various types of seizures, including generalized...
Read More...
Nov 16, 2020
Potential and growth of the current market The major drawback of the current antiepileptic drugs (AEDs) is their modest efficacy even at best; therefore, many patients require as many as four concurrent AEDs and contend with their host of side effects. The epilepsy market has witnessed several approvals in the l...
Read More...
Mar 25, 2019
What is Epilepsy? Epilepsy is a neurological disorder which mainly affects the central nervous system. It is a chronic and non-communicable disorder associated with unpredictable seizures which affect the body and can result in injuries hence is a physical condition too. Anyone can develop Epilepsy at any a...
Read More...
Mar 21, 2019
Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV) to Biohaven Pharmaceuticals. The voucher was issued under U.S. Food and Drug Administration programme to accelerate speedy recovery of rare ...
Read More...
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Nov 04, 2025
Wireless Brain Sensors: Revolutionizing Neuroscience and Healthcare
Oct 28, 2025
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
Newsletter/Whitepaper